Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Ellipsys vascular access system
Build a successful program for the Ellipsys™ vascular access system with resources and best practices designed to enhance patient selection, fistula creation, maturation, and cannulation.
To deliver the best patient outcomes with the Ellipsys system, healthcare practitioners need to develop a support program with four fundamental pillars:
Early vein mapping is critical for establishing patient qualification.
Vein rescreening on the day of the procedure helps confirm patient readiness and prepare the care team to perform the procedure successfully.
Ellipsys offers the simplest, most minimally invasive option for arteriovenous fistula (AVF) creation.*1,2 With best-in-class training and education from Medtronic, vascular surgeons, interventional radiologists, and interventional nephrologists can perform the Ellipsys procedure.
Watch the video to see exactly how the Ellipsys procedure is performed.
Track flow volume of the fistula to determine appropriate vessel maturation strategy for a target cannulation vessel with:
One-week follow-up
Verify anastomosis or perform balloon dilation if necessary.
Four-week follow-up
Perform fistula preparation to direct flow to target vein.
Six- to eight-week follow-up
Establish two-needle cannulation.
Dialysis center staff should be aware of the following variations with Ellipsys fistulas.
Look: Swelling, hematoma, aneurysm, edema, presence of multiple collateral vessels, drainage, bleeding, discoloration (pallor, redness), ischemia, ulceration
Listen: Systolic and diastolic bruit near anastomosis
Feel: Thrill near anastomosis, pulsatile, weak, firm, tender, thrombosed
Learn about industry-leading technology and tools that help improve patient outcomes for Ellipsys procedures, including courses, webinars, videos and more.
See what makes Ellipsys the simplest, most minimally invasive option for AVF creation.
Per instructions for use (IFU).
Compared to surgical arteriovenous fistulas.
Hull JE, Jennings WC, Cooper RI, Waheed U, Schaefer ME, Narayan R. The pivotal multicenter trial of ultrasound-guided percutaneous arteriovenous fistula creation for hemodialysis access. J Vasc Interv Radiol. February 2018;29(2):149-158.e5.
Shahverdyan R, Beathard G, Mushtaq N, et al. Comparison of Ellipsys percutaneous and proximal forearm Gracz-type surgical arteriovenous fistulas. Am J Kidney Disease. October 2021;78(4):520-529.
Franco G, Mallios A, Bourquelet P, Hebibi H, Jennings W, Boura B. Feasibility for arteriovenous fistula creation with Ellipsys. J Vasc Access. September 2020;21(5):701-704.
Hull J, Deitrick J, Groome K. Maturation for hemodialysis in the Ellipsys post-market registry. J Vasc Interv Radiol. September 2020;31(9):1373-1381.
Shahverdyan R, Beathard G, Mushtaq N, Litchfield TF, Nelson PR, Jennings WC. Comparison of outcomes of percutaneous arteriovenous fistulae creation by Ellipsys and WavelinQ devices. J Vasc Interv Radiol. September 2020;31(9):1365-1372.
Popli K, Dittman JM, Amendola MF, Plum J, Newton DH. Anatomic suitability for commercially available percutaneous arteriovenous fistula creation systems. J Vasc Surg. March 2021;73(3):999-1004.